CT-guided 125I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study Cover

.blurhash-client-img { display: none !important; }

CT-guided 125I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study

Radiology and Oncology

Volume 57 (2023): Issue 1 (March 2023)

By: Zixiong Chen, Xiaobo Fu, Zhenkang Qiu, Maoyuan Mu, Weiwei Jiang, Guisong Wang, Zhihui Zhong, Han Qi and Fei Gao

Open Access

|Mar 2023

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2023-0012 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 127 - 139

Submitted on: Dec 29, 2022

Accepted on: Jan 30, 2023

Published on: Mar 22, 2023

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

hepatocellular carcinoma,

high-risk location,

transarterial chemoembolization,

microwave ablation,

¹²⁵I brachytherapy

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2023 Zixiong Chen, Xiaobo Fu, Zhenkang Qiu, Maoyuan Mu, Weiwei Jiang, Guisong Wang, Zhihui Zhong, Han Qi, Fei Gao, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 57 (2023): Issue 1 (March 2023)Next article